A MORAY CARE home that was heavily criticised by inspectors earlier this year has been put up for sale.
The Lythe Care Home near Cullen is on the market at offers over £1.3million just months after the Care Inspectorate officers said they had concerns over the “dignity and safety” of residents.
Now the Inspectorate has confirmed the operators of the home, RDS Healthcare, had decided to offer the business for sale as a going concern.
A Care Inspectorate spokesman said: “The Inspectorate is in close contact with the provider to ensure that residents’ needs continue to be met and their rights respected during this process.”
When Inspectors visited the home to carry out unannounced inspections their report criticised the home for the “weak” quality of care and support it offered.
The Inspectorate recognised that many staff had been working for a number of years at the home and knew the needs of their residents well – but several aspects of care and management were not up to standard and had failed to act on prior warnings.
Lythe Care Home also hit the headlines last year when a nurse employed there was given a four-year caution order after being found with the Class B drug ‘Speed’ on the premises.
They care home is registered to care for 36 residents and is now being offered for sale at offers over £1,325,000.